Table 2

Adverse events at least possibly attributable to XmAb5574

Toxicity0.3 mg/kg (N = 1)1 mg/kg (N = 1)3 mg/kg (N = 3)6 mg/kg (N = 3)9 mg/kg (N = 3)12 mg/kg (N = 16)Total (%)
Any event 14 24 (88.9) 
DLTs        
 Grade 4 neutropenia lasting ≥7 d with febrile neutropenia      1 (3.7) 
Other grade 3/4 toxicities        
 Neutropenia     2(7.4) 
 Thrombocytopenia      2(7.4) 
 Tumor lysis syndrome      1(3.7) 
 Increased AST      1(3.7) 
Grade 1/2 toxicities occurring in >1 patient        
 Infusion reaction 11 18(66.7) 
 Increased AST    4(14.8) 
 Increased alanine aminotransferase    5(18.5) 
 Neutropenia     2(7.4) 
 Thrombocytopenia     3(11.1) 
 Fever   4(14.8) 
 Chills    3(11.1) 
 Peripheral sensory neuropathy     3(11.1) 
 Diarrhea     2(7.4) 
 Flushing     2(7.4) 
 Hyperuricemia     2(7.4) 
 Hypocalcemia     2(7.4) 
 Increased lipase     2(7.4) 
Toxicity0.3 mg/kg (N = 1)1 mg/kg (N = 1)3 mg/kg (N = 3)6 mg/kg (N = 3)9 mg/kg (N = 3)12 mg/kg (N = 16)Total (%)
Any event 14 24 (88.9) 
DLTs        
 Grade 4 neutropenia lasting ≥7 d with febrile neutropenia      1 (3.7) 
Other grade 3/4 toxicities        
 Neutropenia     2(7.4) 
 Thrombocytopenia      2(7.4) 
 Tumor lysis syndrome      1(3.7) 
 Increased AST      1(3.7) 
Grade 1/2 toxicities occurring in >1 patient        
 Infusion reaction 11 18(66.7) 
 Increased AST    4(14.8) 
 Increased alanine aminotransferase    5(18.5) 
 Neutropenia     2(7.4) 
 Thrombocytopenia     3(11.1) 
 Fever   4(14.8) 
 Chills    3(11.1) 
 Peripheral sensory neuropathy     3(11.1) 
 Diarrhea     2(7.4) 
 Flushing     2(7.4) 
 Hyperuricemia     2(7.4) 
 Hypocalcemia     2(7.4) 
 Increased lipase     2(7.4) 

or Create an Account

Close Modal
Close Modal